Boston Scientific to Miss Revenue

Elena
22 Sep, 2006
New York City

The company said Q3 net earnings are expected to come in the range of a penny and 5 cents a share. On an adjusted basis, Boston Scientific forecast earnings of $230 million to $290 million, or 15 cents to 19 cents a share. Analysts are expecting Q3 per-share earnings of 16 cents a share, on average. The company said Q3 net sales were seen between $1.97 billion and $2.035 billion vs. an average forecast of $2.175 billion.

[R]8:00AM Boston Scientific to miss Q3 revenue forecast.[/R]
Boston Scientific Corp. ((BSX)) released its Q3 earnings and revenue forecast. The company said Q3 net earnings are expected to come in the range of a penny and 5 cents a share. Excluding charges related to its acquisition of Guidant, net profit is seen between $90 million and $145 million, or 6 cents and 10 cents a share. On an adjusted basis, Boston Scientific forecast earnings of $230 million to $290 million, or 15 cents to 19 cents a share. Analysts are expecting Q3 per-share earnings of 16 cents a share, on average.

The medical device maker projected Q2 revenue below analyst expectations, citing a contraction in the cardiac rhythm management market and a slowdown in the drug-eluting stent market. Stents are small metal devices that are inserted into clogged arteries in order to keep them open. Boston Scientific forecast worldwide sales of its Taxus paclitaxel-eluting coronary stent systems will range between $550 million and $580 million in third quarter. The company said Q3 net sales were seen between $1.97 billion and $2.035 billion vs. an average forecast of $2.175 billion. In after-hours trading shares of the company fell 4%. On Friday Prudential cut Boston Scientific target to $14 from $21.


[R]7:30AM Asian markets fall tracking U.S. decline on weak economic data.[/R]
Asian markets were lower on Friday. The Nikkei 225 Average in Japan finished the day 1.26% lower at 15634.67. Stocks dropped to a six-week low as declines in U.S. markets and a stronger yen led to selling in exporter issues such as Canon, Bridgestone and Toyota. Canon shed 2.8%, Bridgestone lost 1.1% and Toyota sank 1.1%. Toshiba ended 2% lower and Honda slipped 1%. Sony finished 1.9% lower, suffering only limited impact from news that its videogame subsidiary will reduce the planned retail price for the next-generation PlayStation 3 console by 20%.

The Hang Seng Index in Hong Kong lost 0.11% to 17600.65. Shares ended lower after reaching a six-year high Thursday, with drops led by fashion retailer Esprit, which shed 2.9%. The Shanghai Composite Index ended 0.9% lower at 1725.36. China Minsheng Banking dropped 3.7% and Shanghai Pudong Development Bank slid 2.3%.

The Kospi Index in South Korea declined 1.35% to close at 1348.38. The market finished lower on worries over the U.S. economic slowdown and profit-taking, especially in transportation shares. Korean Air dropped 3.5% and Hyundai Merchant Marine shed 4.2% on profit-taking following recent gains spurred by lower oil prices.

Taiwan dropped 0.06% to 6885.60. Taiwan Semiconductor Manufacturing fell 1.3% and United Microelectronics declined 0.5%. Australia S&P/ASX 200 dropped 0.25% to finish at 4983.20. Weak bank shares pulled the Australian stock market lower for the fourth consecutive day. ANZ retreated 1.1% and Westpac fell 0.9%. But miners made ground after reaching multi-month lows this week, as BHP added 1% and Rio Tinto rose 2.9%.


[R]6:30AM European markets fall sharply on Philadelphia Fed data.[/R]
European markets declined on Friday. The FTSE 100 dropped 1% to 5,835.5, the Xetra Dax in Frankfurt fell 1.1% to 5,898.07 and the CAC-40 fell 1% to 5,154.11.

Corporate News

KPN agreed to sell its entire remaining 8% stake in the telecoms group. The government will sell about 87 million ordinary shares through an accelerated bookbuilding and a further 80 million ordinary shares will be repurchased by KPN, which will then cancel them. KPN fell 1.8%.

Advancers
Altana, the German pharmaceuticals and chemicals group rose 1.4%. On Thursday, Altana said it would sell its drugs business to Nycomed. Euronext, the operator of the Paris, Brussels, Amsterdam and Lisbon bourses added 1.7%. Metrovacesa added 4.3% after the two largest shareholders battling for control of largest property group in Spain failed to achieve a decisive position.

Decliners

Commerzbank fell 2.5% after Dresdner Kleinwort lowered its price target and Renault shares were down 0.8% in Paris after reports emerged overnight that talks between the French company and General Motors Corp. evaluating a possible alliance have stalled. Oil futures added 32 cents to stand at $61.91 a barrel, putting some pressure on airlines such as British Airways, trading down 1.3%., and auto stocks such as Volkswagen moving down 1.2%.

Oil and Gold

Oil prices advanced on Friday, bouncing back from a midweek drop sparked by figures showing a surge in U.S. distillate supplies. Light, sweet crude oil for November delivery gained 32 cents to $61.91 a barrel in electronic trading on the NYME. The gold bullion opened Friday at a bid price of $586.45 a troy ounce, up from $579.20 late Thursday.

Currencies

The euro rose against the U.S. dollar on Friday as traders favored the common currency after weak economic reports in the United States. In morning trading, the euro rose to $1.2818, up from $1.2766 late Thursday in New York. The British pound advanced to $1.9053 from $1.8990 late Thursday and the dollar slipped to 116.36 Japanese yen from 116.61 yen.